PL374198A1 - Novel combination - Google Patents

Novel combination

Info

Publication number: PL374198A1
Authority: PL; Poland
Prior art keywords: novel combination; novel; combination
Prior art date: 2002-05-23

Application number

PL03374198A

Other languages

English (en)

Polish (pl)

Inventor

David Natham Abraham Fox

Bernadette Hughes

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-23

Filing date

2003-05-09

Publication date

2005-10-03

2002-05-23 Priority claimed from GB0211919A external-priority patent/GB0211919D0/en

2002-12-20 Priority claimed from GB0229784A external-priority patent/GB0229784D0/en

2003-05-09 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2005-10-03 Publication of PL374198A1 publication Critical patent/PL374198A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Endocrinology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL03374198A 2002-05-23 2003-05-09 Novel combination PL374198A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0211919A GB0211919D0 (en)	2002-05-23	2002-05-23	Novel combination
GB0229784A GB0229784D0 (en)	2002-12-20	2002-12-20	Novel combination

Publications (1)

Publication Number	Publication Date
PL374198A1 true PL374198A1 (en)	2005-10-03

Family

ID=29585817

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03374198A PL374198A1 (en)	2002-05-23	2003-05-09	Novel combination

Country Status (18)

Country	Link
EP (1)	EP1506015A2 (xx)
JP (1)	JP2005529927A (xx)
KR (1)	KR20050004195A (xx)
CN (1)	CN1655820A (xx)
AR (1)	AR040090A1 (xx)
AU (1)	AU2003223071A1 (xx)
BR (1)	BR0311191A (xx)
CA (1)	CA2485984A1 (xx)
IL (1)	IL164975A0 (xx)
MX (1)	MXPA04010951A (xx)
NO (1)	NO20045517L (xx)
PA (1)	PA8574201A1 (xx)
PE (1)	PE20040514A1 (xx)
PL (1)	PL374198A1 (xx)
RU (1)	RU2004133973A (xx)
TW (1)	TW200407153A (xx)
UY (1)	UY27816A1 (xx)
WO (1)	WO2003099194A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7019010B2 (en)	2001-09-27	2006-03-28	Novertis Ag	Combinations
GB0318094D0 (en) *	2003-08-01	2003-09-03	Pfizer Ltd	Novel combination
DE102004011512B4 (de)	2004-03-08	2022-01-13	Boehringer Ingelheim Vetmedica Gmbh	Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en)	2004-03-25	2005-09-28	Boehringer Ingelheim Vetmedica Gmbh	Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en)	2004-03-25	2015-03-17	Boehringer Ingelheim Vetmedica Gmbh	Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
FR2902009B1 (fr) *	2006-06-13	2012-12-07	Bioprojet Soc Civ	Utilisation d'un inhibiteur de vasopeptidase pour le traitement de l'hypertension arterielle pulmonaire
EP2061322B1 (en)	2006-08-24	2015-07-01	Surface Logix, Inc.	Pharmacokinetically improved compounds
EP1920785A1 (en)	2006-11-07	2008-05-14	Boehringer Ingelheim Vetmedica Gmbh	Liquid preparation comprising a complex of pimobendan and cyclodextrin
WO2013135852A1 (en)	2012-03-15	2013-09-19	Boehringer Ingelheim Vetmedica Gmbh	Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
DK3021832T3 (da)	2013-07-19	2021-05-25	Boehringer Ingelheim Vetmedica Gmbh	Konserverede etherificerede cyclodextrinderivater indeholdende flydende vandig farmaceutisk sammensætning
ES2593210T3 (es)	2013-12-04	2016-12-07	Boehringer Ingelheim Vetmedica Gmbh	Composiciones farmacéuticas mejoradas de pimobendán
US10537570B2 (en)	2016-04-06	2020-01-21	Boehringer Ingelheim Vetmedica Gmbh	Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4316906A (en) *	1978-08-11	1982-02-23	E. R. Squibb & Sons, Inc.	Mercaptoacyl derivatives of substituted prolines
GB9013750D0 (en) *	1990-06-20	1990-08-08	Pfizer Ltd	Therapeutic agents
GB9401090D0 (en) *	1994-01-21	1994-03-16	Glaxo Lab Sa	Chemical compounds
US6143746A (en) *	1994-01-21	2000-11-07	Icos Corporation	Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
IL135462A0 (en) *	1997-11-12	2001-05-20	Bayer Ag	2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
EA200200240A1 (ru) *	1999-10-11	2002-10-31	Пфайзер Инк.	5-(2-ЗАМЕЩЕННЫЕ-5-ГЕТЕРОЦИКЛИЛСУЛЬФОНИЛПИРИД-3-ИЛ)-ДИГИДРОПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ФОСФОДИЭСТЕРАЗЫ
TWI265925B (en) *	1999-10-11	2006-11-11	Pfizer	Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

2003
- 2003-05-09 EP EP03719042A patent/EP1506015A2/en not_active Withdrawn
- 2003-05-09 BR BR0311191-1A patent/BR0311191A/pt not_active IP Right Cessation
- 2003-05-09 KR KR10-2004-7018868A patent/KR20050004195A/ko not_active Abandoned
- 2003-05-09 MX MXPA04010951A patent/MXPA04010951A/es unknown
- 2003-05-09 WO PCT/IB2003/001889 patent/WO2003099194A2/en not_active Ceased
- 2003-05-09 JP JP2004506721A patent/JP2005529927A/ja not_active Abandoned
- 2003-05-09 CA CA002485984A patent/CA2485984A1/en not_active Abandoned
- 2003-05-09 RU RU2004133973/15A patent/RU2004133973A/ru not_active Application Discontinuation
- 2003-05-09 AU AU2003223071A patent/AU2003223071A1/en not_active Abandoned
- 2003-05-09 CN CNA038118262A patent/CN1655820A/zh active Pending
- 2003-05-09 PL PL03374198A patent/PL374198A1/xx not_active Application Discontinuation
- 2003-05-12 TW TW092112826A patent/TW200407153A/zh unknown
- 2003-05-19 PE PE2003000482A patent/PE20040514A1/es not_active Application Discontinuation
- 2003-05-21 AR ARP030101762A patent/AR040090A1/es unknown
- 2003-05-21 UY UY27816A patent/UY27816A1/es not_active Application Discontinuation
- 2003-05-22 PA PA20038574201A patent/PA8574201A1/es unknown
2004
- 2004-11-01 IL IL16497504A patent/IL164975A0/xx unknown
- 2004-12-17 NO NO20045517A patent/NO20045517L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL164975A0 (en)	2005-12-18
JP2005529927A (ja)	2005-10-06
UY27816A1 (es)	2003-12-31
WO2003099194A2 (en)	2003-12-04
AR040090A1 (es)	2005-03-16
TW200407153A (en)	2004-05-16
KR20050004195A (ko)	2005-01-12
PA8574201A1 (es)	2003-12-19
RU2004133973A (ru)	2005-09-10
AU2003223071A1 (en)	2003-12-12
WO2003099194A3 (en)	2004-06-03
MXPA04010951A (es)	2005-06-08
EP1506015A2 (en)	2005-02-16
CA2485984A1 (en)	2003-12-04
BR0311191A (pt)	2005-03-01
PE20040514A1 (es)	2004-08-24
CN1655820A (zh)	2005-08-17
NO20045517L (no)	2004-12-17

Publication	Publication Date	Title
DE50311874D1 (en)	2009-10-15	Spirocyclische cyclohexan-derivate
DE50312422D1 (en)	2010-04-01	Aryloxime
IL166084A0 (en)	2006-01-15	Novel benzodioxoles
PL371678A1 (en)	2005-06-27	Novel pyridin- and pyrimidin-derivatives
PL373598A1 (en)	2005-09-05	Novel benzonaphthyridines
AU2003249738A8 (en)	2004-01-23	Ostoscope
AU2003297193A8 (en)	2004-07-09	Meta-web
DE50309217D1 (en)	2008-04-03	Benzimidazolderivate
AU2003252028A8 (en)	2004-02-09	Heterodiamondoids
IL163529A0 (en)	2005-12-18	Novel spinosyn-producing polyketidesynthases
AU2003279495A8 (en)	2004-05-13	Alert-modeling
DE50303619D1 (en)	2006-07-06	Reibschweissvorrichtung
DE50307787D1 (en)	2007-09-06	Isophthalsäurederivate
DE50311133D1 (en)	2009-03-12	Carbonsäureamide
DE50312412D1 (en)	2010-03-25	4-hydroxymethyl-1-aryl-cyclohexylamin-derivative
IL164975A0 (en)	2005-12-18	Novel combination
AU2003264900A8 (en)	2004-04-08	Cast-cutter
DE50310169D1 (en)	2008-08-28	Lingual-retainer
GB0214784D0 (en)	2002-08-07	Novel combination
AU2002367810A8 (en)	2003-11-10	Bis-transition-metal-chelate-probes
GB0225873D0 (en)	2002-12-11	Combination
AU2003262681A8 (en)	2004-03-03	Hemo-aide
DE10392833D2 (en)	2005-06-09	Geotextilie
AU2003253735A8 (en)	2004-01-06	Vacuolins
GB0229743D0 (en)	2003-01-29	Novel benzoxazocines

Legal Events

Date	Code	Title	Description
2011-01-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)